News

Find News

Filter articles

Showing 2601 to 2610 of 2884 results

Genentech refused appeal in Herceptin case

UK27-05-2014Legal developments

Justice Colin Birss has refused Roche’s biotechnology subsidiary Genentech the permission to appeal against an English High Court decision in which two patents covering its blockbuster breast cancer drug, Herceptin (trastuzumab), were revoked.

Acura ends all Aversion litigation with final Sandoz settlement

US23-05-2014Legal developments

US-based drug company Acura and Novartis’s generic arm Sandoz have settled their patent infringement dispute related to an abuse-deterrent formulation of the painkiller Aversion (oxycodone).

Mylan quashes morning-after pill dosage patent

UK22-05-2014Legal developments

Generics (UK) Limited, the UK arm of Mylan, has succeeded in invalidating a patent held by Hungarian pharmaceutical company Richter Gedeon at the English High Court.

Medtronic and Edwards settle heart valve litigation

US21-05-2014Legal developments

Medical device rivals Medtronic and Edwards Lifesciences have agreed to settle all patent litigation, including cases related to transcatheter heart valves.

UNDP urges use of competition law to boost healthcare access

20-05-2014

The United Nations Development Programme has released a guidebook for low- to middle- income countries on how to increase access to essential health technologies and HIV treatments by using competition law and policy.

US court denies Teva’s final shot at blocking Copaxone copies

US19-05-2014Legal developments

A US district court has dismissed Teva’s case against the FDA aimed at stopping the administration from approving generic versions of its blockbuster multiple sclerosis drug Copaxone (glatiramer acetate).

Lilly’s Alimta dosage patent invalidated at English High Court

UK16-05-2014Legal developments

The English High Court has ruled that a patent covering vitamin dosage regimens for Eli Lilly’s lung cancer drug Alimta (pemetrexed disodium) would not be infringed by generic competitors.

Sun and Novartis settle on Gleevec

US15-05-2014

Novartis and Sun Pharma’s US subsidiary have settled litigation related to cancer drug Gleevec (imatinib mesylate) in the US, the companies announced today (May 15).

Janssen sues to halt Mylan’s Concerta generic

US14-05-2014Legal developments

Johnson & Johnson’s pharmaceuticals subsidiary Janssen has sued Mylan to stop it launching a generic version of Concerta (methylphenidate hydrochloride).

Valeant agrees to license Acanya in Actavis settlement

US13-05-2014Legal developments

Canadian pharmaceutical company Valeant announced yesterday (May 12) that it had settled all litigation related to its acne treatment Acanya (clindamycin phosphate and benzoyl peroxide) with Actavis.

Showing 2601 to 2610 of 2884 results

LSIPR